$8.35
00.00%
Pre-Market: 4:00 PM EDT
15 minutes delayed
Pulmonx reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Pulmonx using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-07-31 | $-0.39 | $-0.42 | 7.14 % |
Mar 2024 | 2024-05-01 | $-0.36 | $-0.46 | 21.7 % |
Dec 2023 | 2024-02-21 | $-0.36 | $-0.41 | 12.2 % |
Sep 2023 | 2023-10-30 | $-0.39 | $-0.43 | 9.30 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-07-31 | $20.78M | $20.13M | 3.24 % |
Mar 2024 | 2024-05-01 | $18.85M | $17.89M | 5.39 % |
Dec 2023 | 2024-02-21 | $19.28M | $18.27M | 5.50 % |
Sep 2023 | 2023-10-30 | $17.67M | $16.39M | 7.80 % |
Pulmonx (LUNG) is scheduled to report earnings on October 28, 2024. The last reported earnings were for reported on July 31, 2024 for Q2.
The Actual EPS was $-0.39, which beat the estimate of $-0.42.
The Actual Revenue was $20.8M, which beat the estimate of $20.1M.
Browse earnings estimates, EPS, and revenue on all stocks.